Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of generic sitagliptin + metformin vs Janumet 50/1000 mg under fed conditions
TCTR20260405006Phase 1Not yet recruiting
- Sponsor
- International Bio Service
- Start
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of sitagliptin + metformin, sitagliptin and metformin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by International Bio Service. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
sitagliptin + metforminsitagliptinmetformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on TCTR20260405006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260405006.